These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 6843720

  • 1. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A, Hristescu S, Mazilu E.
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [Abstract] [Full Text] [Related]

  • 2. [The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].
    Donenko FV, Kabieva AO, Moroz LV.
    Biull Eksp Biol Med; 1992 Jul; 114(8):191-3. PubMed ID: 1467491
    [Abstract] [Full Text] [Related]

  • 3. Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice.
    Sheeja K, Kuttan G.
    Integr Cancer Ther; 2007 Mar; 6(1):66-73. PubMed ID: 17351028
    [Abstract] [Full Text] [Related]

  • 4. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
    Donenko FV, Kabieva AO, Moroz LV.
    Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
    [Abstract] [Full Text] [Related]

  • 5. [Effect of the nucleic acids from the ascitic fluid of Ehrlich's tumor on its transplantability].
    Belokhvostov AS, Grikurova NK.
    Vopr Onkol; 1981 Jul; 27(12):56-9. PubMed ID: 7324403
    [Abstract] [Full Text] [Related]

  • 6. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
    Yumura M.
    Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
    [Abstract] [Full Text] [Related]

  • 7. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
    Rivera LM, Lopez DM.
    Anticancer Res; 1993 Feb; 13(1):177-84. PubMed ID: 8476211
    [Abstract] [Full Text] [Related]

  • 8. Effect of cyclophosphamide on tumor cell sensitivity to the action of immunological effectors.
    Culo F, Marić M, Morović-Vergles J.
    In Vivo; 1995 Feb; 9(5):439-46. PubMed ID: 8900921
    [Abstract] [Full Text] [Related]

  • 9. Antitumor effect of lymphocyte and macrophage from mice immunized with Ehrlich ascites tumor cells.
    Sakashita T.
    Mie Med J; 1971 Jan; 20(3):227-41. PubMed ID: 5558109
    [No Abstract] [Full Text] [Related]

  • 10. In vivo activity of spleen cells from untreated syngeneic mice against Ehrlich ascites carcinoma.
    Jakóbisiak M, Kawiak J, Kawalec M, Kańtoch M, Kamiński M, Rozmysłowicz T.
    Folia Biol (Praha); 1979 Jan; 25(3):169-78. PubMed ID: 488466
    [Abstract] [Full Text] [Related]

  • 11. Concentration of fibronectin in plasma of tumor-bearing mice and synthesis by Ehrlich ascites tumor cells.
    Zardi L, Cecconi C, Barbieri O, Carnemolla B, Picca M, Santi L.
    Cancer Res; 1979 Sep; 39(9):3774-9. PubMed ID: 383288
    [Abstract] [Full Text] [Related]

  • 12. Amentoflavone, a biflavonoid from Biophytum sensitivum augments lymphocyte proliferation, natural killer cell and antibody dependent cellular cytotoxicity through enhanced production of IL-2 and IFN-gamma and restrains serum sialic acid and gamma glutamyl transpeptidase production in tumor - bearing animals.
    Guruvayoorappan C, Kuttan G.
    J Exp Ther Oncol; 2007 Sep; 6(4):285-95. PubMed ID: 18038762
    [Abstract] [Full Text] [Related]

  • 13. Chalone-like inhibition of Ehrlich ascites cell proliferation in vitro by an ultrafiltrate obtained from the ascitic fluid.
    Lehmann W, Graetz H, Schütt M, Langen P.
    Acta Biol Med Ger; 1977 Sep; 36(7-8):K 43-52. PubMed ID: 148196
    [Abstract] [Full Text] [Related]

  • 14. A factor responsible for increases in ornithine decarboxylase activity in the livers of tumor-bearing mice.
    Noguchi T, Kashiwagi A, Tanaka T.
    Cancer Res; 1976 Nov; 36(11 Pt 1):4015-22. PubMed ID: 975047
    [Abstract] [Full Text] [Related]

  • 15. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N, Naraparaju VR.
    Cancer Res; 1997 Jun 01; 57(11):2187-92. PubMed ID: 9187119
    [Abstract] [Full Text] [Related]

  • 16. Proliferative response of T lymphocytes to allogeneic tumor without generation of killer T lymphocytes in the presence of Ehrlich ascites tumor fluid.
    Laurence JC, Hamaoka T, Kitagawa M.
    Gan; 1976 Jun 01; 67(3):417-23. PubMed ID: 137160
    [Abstract] [Full Text] [Related]

  • 17. [Effect oh millimeter waves on the immune system in mice with experimental tumors].
    Novoselova EG, Ogaĭ VB, Sinotova OA, Glushkova OV, Sorokina OV, Fesenko EE.
    Biofizika; 2002 Jun 01; 47(5):933-42. PubMed ID: 12397969
    [Abstract] [Full Text] [Related]

  • 18. Study of interactions between Listeria monocytogenes and experimental tumors.
    Krybus J, Bueno MA, Feder D, Andrade Júnior AF, Cabral M, Novak A, Martins MC.
    Rev Paul Med; 1992 Jun 01; 110(3):102-7. PubMed ID: 1340994
    [Abstract] [Full Text] [Related]

  • 19. [Nonspecific suppressive effect of Ehrlich tumor ascitic fluid on transplantation immunity].
    Belokhvostov AS, Zelenkova NK.
    Biull Eksp Biol Med; 1978 Oct 01; 86(10):474-6. PubMed ID: 361103
    [Abstract] [Full Text] [Related]

  • 20. Antibody-dependent lysis of tumor cells in vivo. II. Elimination of chromium-51 as a measurement of cytolysis.
    Scornik JC, Klein PA.
    J Natl Cancer Inst; 1978 Oct 01; 61(4):1149-54. PubMed ID: 212569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.